Drugging SUMOylation for neuroprotection and oncotherapy.

about

Drugging SUMOylation for neuroprotection and oncotherapy.

Item

http://www.wikidata.org/entity/Q52721191

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Drugging SUMOylation for neuroprotection and oncotherapy.

@en

Drugging SUMOylation for neuroprotection and oncotherapy.

@nl

type

Item

label

Drugging SUMOylation for neuroprotection and oncotherapy.

@en

Drugging SUMOylation for neuroprotection and oncotherapy.

@nl

prefLabel

Drugging SUMOylation for neuroprotection and oncotherapy.

@en

Drugging SUMOylation for neuroprotection and oncotherapy.

@nl

P1476

Drugging SUMOylation for neuroprotection and oncotherapy.

@en

P2093

Daniel G Ye

http://www.w3.org/2001/XMLSchema#string

Florian Gessler

http://www.w3.org/2001/XMLSchema#string

John M Hallenbeck

http://www.w3.org/2001/XMLSchema#string

Wei Zheng

http://www.w3.org/2001/XMLSchema#string

Yang-Ja Lee

http://www.w3.org/2001/XMLSchema#string

P2860

SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer

Sumoylation: a regulatory protein modification in health and disease.

Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure.

A novel quantitative high-throughput screen identifies drugs that both activate SUMO conjugation via the inhibition of microRNAs 182 and 183 and facilitate neuroprotection in a model of oxygen and glucose deprivation.

Drug combination therapy increases successful drug repositioning.

Global SUMOylation facilitates the multimodal neuroprotection afforded by quercetin against the deleterious effects of oxygen/glucose deprivation and the restoration of oxygen/glucose.

Spectomycin B1 as a novel SUMOylation inhibitor that directly binds to SUMO E2.

Combining Neuroprotection With Endovascular Treatment of Acute Stroke: Is There Hope?

Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming.

SUMOylation in brain ischemia: Patterns, targets, and translational implications.

P304

415-416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1673-5374.228718

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gregory K Friedman

Joshua D. Bernstock

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29623920

http://www.w3.org/2001/XMLSchema#string

P932

5900498

http://www.w3.org/2001/XMLSchema#string